Most Recent Episode
Join board member, Cheryl Bruner, Esq., as she sits down with Joe Belluck, Esq., of Belluck & Fox, LLP to discuss the most asked questions from mesothelioma patients and families about legal issues.
00:00 Introduction
1:11 Why Belluck & Fox chooses to sponsor the Meso Foundation and how their mission resonates
6:15 How Belluck & Fox works within the meso community
7:47 Next steps in the legal process after diagnosis
11:05 Litigation timeline after choosing a law firm
14:01 How much time and effort is anticipated to dedicate to litigation
16:14 Options for taking legal action
21:58 Timeline of settlement funds
28:05 How much of a settlement does a patient/family receive
35:37 Advice for future clients in deciding legal action
This program was made possible by a generous educational grant from Belluck & Fox.
Hear directly from experts in the field of mesothelioma about topics that impact you!
As part of the Meet the Mesothelioma Experts (MTME) series, the Meso Foundation invites specialists in the field of mesothelioma to discuss their current research interests as well as promising developments in the treatment of mesothelioma. Below, you can view and listen to our past sessions.
Interested in being a speaker?
Interested in participating in our MTME as a guest speaker? Contact us at [email protected] or 703-879-3797.
Past Episodes
- Asbestos Litigations Questions Answered
- Immunotherapy for mesothelioma: What’s Next?
- YOUR legal questions answered in this special legal edition of Meet the Mesothelioma Experts.
- Present and Future of Immunotherapy Treatment for Mesothelioma
- Meet the Mesothelioma Experts: Legal Edition w/ Maune Raichle Hartley French & Mudd, LLC (MRHFM) law firm
- Special MTME: Legal Edition with Joe Belluck, of Belluck & Fox, LLP
- Discussing the Tumor Treating Fields device for mesothelioma with Dr. Zachary Horne
- Pre-Operative Immunotherapy Clinical Trial with Dr. Patrick Forde of Johns Hopkins
- Mesothelioma Program at Veterans Affairs Medical Center in Houston, Texas
- Phase 3 Study of TR002, an adenovirus-mediated interferon alfa 2b with Dr. Steve Albelda & Dr. Daniel Sterman
- Breath test for early detection of mesothelioma is in the works with Dr. Michael Harbut
- Front-line clinical trial for non-epithelioid mesothelioma with Dr. Marjorie G. Zauderer and Dr. John Bomalaski
- An Interview with Aduro Biotech
- An Interview with William A. Franco and Julie P. Pawelczyk of The Conafay Group
- Targeting the Immune System with Daniel H. Sterman, MD
- Meet Marjorie Zauderer, MD, of Memorial Sloan Kettering Cancer Center
- Current Trends in Mesothelioma Surgery and Research: The International Mesothelioma Program at Brigham and Women’s Hospital
- 2015 Grant Recipient Interviews
- Focus on Centers of Excellence: Penn Medicine with Dr. Evan Alley and Dr. Charles Simone
- Focus on Mesothelioma Centers of Excellence with Dr. Hedy Lee Kindler
- CRS-207: Using a Modified Listeria Virus to Fight Mesothelioma with Aduro BioTech
- Mesothelioma Clinical Trial Using PD-L1 Inhibitors with Dr. Evan Alley
- Defactinib, a New Investigational Agent for Mesothelioma, with Dr. Joanna Horobin
- Focused Discussion of a New Clinical Trial: GL-ONC1 with Dr. Valerie Rusch
- New Frontiers in Surgery for Mesothelioma with Dr. Joseph Friedberg
- Designing Clinical Trials for Mesothelioma with Melissa Culligan, RN
- Intrapleural Measles Virus Therapy in patients with malignant pleural mesothelioma with Dr. Tobias Peikert
- NGR-hTTNF: A New Multi-Center Drug Trial for Pleural Mesothelioma with Dr. Julie Brahmer
- Mesothelin: A New Target for Immunotherapy with Dr. Raffit Hassan
- Recent Advances in Mesothelioma Gene Therapy with Dr. Daniel Sterman
- Vaccines: can we manipulate the immune system to prevent recurrence following a PD/EPP?
